It seems that almost every morning this past week I started with the same mantra: Futures are positive in early morning trade, pointing to a higher start for stocks. The bulls were trying really hard it seemed to inject optimism into the market, but every day something happened. If it was economic indicators, oil prices or earnings, every day (even if the market ticked higher at the beginning), stock markets closed down for five sessions in a row.
Well, this morning is no different and the bulls will give it one last shot this week as futures are indeed positive in early morning trade, pointing to a higher start for stocks. The question is what the much anticipated October job report will be like when it is reported at 8:30 a.m., before the market opens.
Nonfarm payroll, one of the many indicators reported by the U.S. Department of Labor Employment Report, is expected to have added 125,000 jobs in October after a 51,000 increase in September. Hourly earnings is forecast to rise by 0.3% in October compared to an increase of 0.2% in September. A 0.3% rise would be a yearly rate of 3.8%.
Another significant data point would be the unemployment rate, which is expected to remain the same at 4.6% after ticking down to that number last month. The question is whether after a week of weak economic reports, could strong employment data help spur a rally and diffuse pessimism.
Adding to the negative sentiment are the comments made by a top Caterpillar, Inc. (NYSE:CAT) executive who said last night that he believes 2007 will be a year of "significant slowdown" in the U.S. housing market. However, he also predicted world-wide faster growth in the next few years (based on Fed rate cuts in 2007).
Top of the news this morning:
A surprising announcement of partnership comes from two old-time rivals, Microsoft Corp. (NASDAQ:MSFT) and Novell, Inc. (NASDAQ:NOVL). The two announced they would collaborate to build, market and support a series of new solutions to make Novell and Microsoft products work better together. That is, Linux, the operating system distributed by Novell, could work with Windows, Microsoft's operating system. Novell shares were up over 15% yesterday before the announcement.
The Federal Communications Commission has delayed its vote again on the proposed $80 billion merger between AT&T Inc. (NYSE:T) and BellSouth Corp (NYSE:BLS).
Qualcomm Inc. (NASDAQ:QCOM) reported fiscal fourth-quarter earnings. Profits rose 14% to $614 million, or 36 cents a share. Revenue jumped 28% to $2 billion. Excluding a 6 cents a share for adjustments, Qualcomm earned 42 cents a share. Analysts had projected a profit of 41 cents a share. The stock fell over 2% in pre-open trading on lower projections.
Electronic Arts, Inc. (NASDAQ:ERTS) shares are rising over 8% in pre-market trading after it reported earnings that beat estimates, boosted its fiscal year guidance and had a positive industry outlook for next year.
On the other hand, Whole Foods Market, Inc. (NASDAQ:WFMI) is losing more than 17% in pre-market trading despite a sharp increase in profit, after the company warned of slower sales growth in 2007.
In Seoul, the appeals court sentenced the founder and former chairman of Daewoo to eight and a half years in prison on a range of charges including embezzlement and accounting fraud. General Motors Corp. (NYSE:GM) acquired a major stake in the collapsed Daewoo Motor to create GM Daewoo in 2002.
Other news:
General Electric Co. (NYSE:GE) lost a contract to Rolls-Royce as Singapore Airlines, said it had chosen the Rolls-Royce Trent 700 engine for the 19 Airbus A330-300s which are due for delivery by 2011.
Fortune analyzes the future of mobile video sharing such as the one Google, Inc.'s (NASDAQ:GOOG) YouTube plans to offer.
Would the election outcome affect pharmaceuticals? Merrill Lynch predicts Big Pharma -- Pfizer, Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK) and Bristol-Myers Squibb Co. (NYSE:BMY) -- and other healthcare companies would be harmed if the Democrats win. However, generic-drug makers, the likes of Barr Pharmaceuticals, Inc. (NYSE:BRL) and Mylan Laboratories, Inc. (NYSE:MYL) would benefit. Find out more on effects of the election outcome on drugs here.